Hyaluronic acid film with excellent percutaneous absorption rate and its manufacturing method
A hyaluronic acid film combining ultra-low and medium molecular weights addresses the challenge of transdermal absorption and stability by achieving high absorption rates and mechanical integrity through specific composition and production methods.
Patent Information
- Application Number
- JP2024531620
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-12-01
- Filing Date
- 2022-10-28
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2042-10-28
AI Technical Summary
Existing hyaluronic acid films face challenges in achieving both high transdermal absorption rates and mechanical stability, with low molecular weight films being easily absorbable but difficult to form, and high molecular weight films having low absorption rates and surface issues.
A hyaluronic acid film composed of 2,000 to 1×10⁴ Da ultra-low molecular weight hyaluronic acid and 1×10⁵ to 1×10⁶ Da medium-molecular weight hyaluronic acid, with a weight ratio of 84.0 to 98.5% to 1.5 to 16%, is produced by filtering the solution, applying it to a mold, and drying at 30 to 60°C, resulting in a thickness of 0.01 to 1.5 mm.
The film achieves a transdermal absorption rate of 72 to 93% with excellent mechanical properties, allowing for uniform production and effective skin permeation.
Smart Images

Figure 2024541568000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to a hyaluronic acid film and a method for producing the same, and more particularly to a hyaluronic acid film having excellent transdermal absorbency and a method for producing the same. [Background technology]
[0002] Hyaluronic acid or hyaluronate is uniformly distributed in the connective tissue, epithelium, and nervous tissue of the human body. It is a biocompatible material with various physiological activities and can contain a large amount of water. It has excellent viscoelasticity, and its effects on skin regeneration, moisturization, elasticity maintenance, and wrinkle improvement have been proven. As a result, the demand for anti-aging cosmetics, foods, medicines, medical device fillers, etc. containing it has been rapidly increasing recently.
[0003] Currently, most finished hyaluronate products on the market are in liquid form and contain excessive amounts of water. Due to concerns about microbial contamination, they must be manufactured in sterile facilities or must contain preservatives, which pose safety concerns, making it difficult to expand their use to industrial applications in terms of versatility and safety.
[0004] Therefore, there has been research into solidifying hyaluronic acid or hyaluronate into films, fibers, etc., rather than into a liquid phase.
[0005] Hyaluronic acid or hyaluronates are classified into ultra-low molecular weight, low molecular weight, medium molecular weight, and high molecular weight according to their molecular weight.
[0006] JP 2014-114355 A discloses an average molecular weight of 1×10 5 ~4×10 6 The Korean Patent Publication No. 2019-0106091 also discloses a medium molecular weight and polymeric hyaluronate film having a molecular weight of 0.1 to 2.5 MDa.
[0007] Medium and high molecular weight hyaluronates have excellent skin coating effects and mechanical properties, making it easy to form films, but they have difficulties in permeating and absorbing through the skin.
[0008] In contrast, hyaluronic acid or hyaluronates with a lower molecular weight are more easily permeated through the skin and absorbed, but have the problem that film production is difficult due to their poor mechanical properties.
[0009] Meanwhile, Korean Patent Publication No. 2019-0138907 discloses that a hyaluronic acid film having a molecular weight of 500 to 5,000,000 Da can be produced, but the molecular weight is not specified in the examples. In fact, when the molecular weight is 2,000 Da or less, a film is not produced, and when the molecular weight is 2,000 to 1×10 4 In the case of a molecular weight of 3.0 × 10 Da, a film is formed, but the surface cracks, reducing marketability. 4 It was confirmed that when the molecular weight exceeds 3.0×10 Da, a film with a uniform surface is formed. 4 Hyaluronic acid films of Da or higher have the problem of low percutaneous absorption rate.
[0010] Therefore, the present inventors have made efforts to produce a hyaluronic acid film that is easily permeable and absorbed through the skin, and as a result, 4 1×10 Da of ultra-low molecular weight hyaluronic acid 5 ~1×10 6 It was confirmed that when a medium molecular weight hyaluronate salt of Da is added, a uniform hyaluronic acid film with excellent transdermal absorption rate can be mass-produced, leading to the completion of the present invention. Summary of the Invention [Problem to be solved by the invention]
[0011] An object of the present invention is to provide a hyaluronic acid film having excellent transdermal absorption rate.
[0012] Another object of the present invention is to provide a method for producing a hyaluronic acid film having excellent percutaneous absorption rate.
[0013] Another object of the present invention is to provide a mask pack, an edible film, and a patch for a medical device, which contain a hyaluronic acid film having excellent transdermal absorption rate. [Means for solving the problem]
[0014] In order to achieve the above object, the present invention provides a hyaluronic acid film having a transdermal absorption rate of 72 to 93%.
[0015] In the present invention, the hyaluronic acid has a molecular weight of 2,000 to 1×10 4 Da of hyaluronic acid 84.0-98.5% by weight and molecular weight 1×10 5 ~1×10 6 It is characterized by being composed of 1.5 to 16 wt % Da of hyaluronic acid.
[0016] In the present invention, the hyaluronic acid film is characterized in that the thickness is 0.01 to 1.5 mm.
[0017] The present invention also provides a polymer having a molecular weight of 2,000 to 1×10 4 Da of hyaluronic acid and molecular weight 1 x 10 5 ~1×10 6 The present invention provides a method for producing a hyaluronic acid film, comprising the steps of: (a) mixing hyaluronic acid having a molecular weight of 1 Da with hyaluronic acid having a molecular weight of 1 Da and dissolving the mixture in a solvent to produce a hyaluronic acid solution; (b) filtering the hyaluronic acid solution; (c) pouring the filtered hyaluronic acid solution into an automatic coater or a mold and casting a film to a thickness of 0.02 to 3 mm; and (d) drying the cast film under conditions of 30 to 60°C.
[0018] In the present invention, the molecular weight is 2,000 to 1 × 10 4 Da of hyaluronic acid and molecular weight 1 x 10 5 ~1×10 6The weight ratio of Da to hyaluronic acid is characterized by being 84.0-98.5% by weight:1.5-16% by weight.
[0019] In the present invention, the viscosity of the hyaluronic acid solution is characterized by being 2,000 to 25,000 cPs.
[0020] In the present invention, the hyaluronic acid solution is characterized in that it has a pH of 2.5 to 3.5.
[0021] In the present invention, the hyaluronic acid is characterized in that it is hyaluronic acid, a hyaluronate salt or a mixture thereof.
[0022] The present invention also provides a cosmetic mask pack, an edible film, and a medical device patch, each of which contains the hyaluronic acid film. Effect of the Invention
[0023] The hyaluronic acid film of the present invention is composed mainly of ultra-low molecular weight hyaluronic acid, and has excellent percutaneous absorption rate as well as excellent mechanical properties. [Brief description of the drawings]
[0024] [Figure 1] This is a photograph of an ultra-low molecular weight hyaluronic acid film. [Diagram 2] This is a hyaluronic acid film produced according to an embodiment of the present invention, which is a mixture of ultra-low molecular weight (8,000 Da) hyaluronic acid and medium molecular weight (1×105 to 1×106 Da) hyaluronic acid. [Diagram 3] 1 is a photograph showing the microbial stability evaluation of a hyaluronic acid film prepared according to an embodiment of the present invention. [Figure 4] 1 is a photograph of a hyaluronic acid film produced without filtering the hyaluronic acid solution. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0025] Hyaluronic acid or hyaluronates having a lower molecular weight are more easily permeated through the skin and absorbed, but have the problem that film production is difficult due to their poor mechanical properties.
[0026] Korean Patent Publication No. 2019-0138907 discloses that a hyaluronic acid film with a molecular weight of 500 to 5,000,000 Da can be produced. However, when the method described in the specification was used, no film was produced when the molecular weight was 2,000 Da or less, and when the molecular weight was 2,000 to 10,000 Da, a film was formed but the surface cracked, reducing marketability, and when the molecular weight was 3×10 4 It was confirmed that a uniform film was formed on the surface when the molecular weight was 3×10 Da or more. 4 Hyaluronic acid films with a hardness of Da or more have a low transdermal absorption rate, which means that the various physiological activities of hyaluronic acid are not properly transmitted to the skin.
[0027] In the present invention, 2,000 to 1 × 10 4 1×10 Da of ultra-low molecular weight hyaluronic acid 5 ~1×10 6 The aim of the study was to confirm that adding Da medium molecular weight hyaluronate would enable mass production of uniform hyaluronic acid films with excellent transdermal absorption rates.
[0028] In the present invention, ultra-low molecular weight hyaluronic acid and medium molecular weight hyaluronic acid are mixed, then dissolved in purified water to produce a hyaluronic acid solution with a viscosity of 2,000 to 25,000 cPs (25°C), which is then poured into an automatic applicator or mold and dried at 30 to 60°C.
[0029] As a result, it was possible to mass-produce hyaluronic acid films with a uniform surface, and it was confirmed that the transdermal absorption rate of the produced hyaluronic acid films was 72-93%.
[0030] Therefore, from one aspect, the present invention relates to a hyaluronic acid film having a transdermal absorption rate of 72 to 93%.
[0031] The hyaluronic acid constituting the hyaluronic acid film has a molecular weight of 2,000 to 1×10 4 Da of hyaluronic acid 84.0-98.5% by weight and molecular weight 1×10 5 ~1×10 6 It is characterized by being composed of 1.5 to 16 wt % Da of hyaluronic acid.
[0032] In other words, the hyaluronic acid film of the present invention is characterized in that a film cannot be formed using only hyaluronic acid having a very low molecular weight, and therefore hyaluronic acid having a medium molecular weight is used together to form the skeleton of the film.
[0033] In the present invention, the molecular weight of hyaluronic acid that corresponds to an ultra-low molecular weight is 2,000 to 1 × 10 4 Da, and the molecular weight of hyaluronic acid, which corresponds to a low molecular weight, is 1×10 4 ~1×10 5 The molecular weight of hyaluronic acid, which is a medium molecule, is 1×10 Da. 5 ~1×10 6 It's Da.
[0034] Molecular weight 2,000~1×10 4 When the hyaluronic acid content of Da is less than 84.0% by weight, a film is formed, but the transdermal absorption rate is low, and when the hyaluronic acid content exceeds 98.5% by weight, no film is formed.
[0035] The hyaluronic acid film of the present invention is characterized by having a thickness of 0.01 to 1.5 mm.
[0036] In the present invention, hyaluronic acid may be hyaluronic acid, hyaluronate, or a mixture thereof. In addition, the hyaluronate is a salt bonded to hyaluronic acid, and examples thereof include, but are not limited to, sodium hyaluronate, calcium hyaluronate, potassium hyaluronate, etc.
[0037] From another viewpoint, the present invention provides a polymer having a molecular weight of 2,000 to 1×10 4 Da of hyaluronic acid and molecular weight 1 x 10 5 ~1×10 6 The present invention relates to a method for producing a hyaluronic acid film, comprising the steps of: (a) mixing hyaluronic acid having a molecular weight of 1 Da with hyaluronic acid having a molecular weight of 1 Da and dissolving the mixture in a solvent to produce a hyaluronic acid solution; (b) filtering the hyaluronic acid solution; (c) pouring the filtered hyaluronic acid solution into an automatic applicator or a mold and casting a film to a thickness of 0.02 to 3 mm; and (d) drying the cast film under conditions of 30 to 60°C.
[0038] Molecular weight 2,000~1×10 4 Da of hyaluronic acid and molecular weight 1 x 10 5 ~1×10 6 The weight ratio of Da to hyaluronic acid is preferably 84.0-98.5% by weight:1.5-16% by weight.
[0039] In the present invention, the viscosity of the hyaluronic acid solution in which ultra-low molecular weight and medium molecular weight hyaluronic acid are mixed is preferably 2,000 to 25,000 cPs (25°C). The viscosity of the solution can vary depending on the HA molecular weight (Da), HA content, and the ratio with the solvent, but if the viscosity is less than 2,000 cPs, it is difficult to form a film, and if the viscosity is more than 25,000 cPs, the surface of the film may become irregular when cast to a thickness of 0.02 mm to 3 mm due to high viscosity.
[0040] Before injecting the mixed hyaluronic acid solution into an automatic applicator or a mold, it is preferable to filter the solution to remove air bubbles and insoluble matter. The filtration can be performed by passing the solution through a sieve (mesh size: 0.1 mm).
[0041] Without the filtration step, cracks will form around the air bubbles or insoluble matter as the film dries, producing a defective film.
[0042] In the present invention, the solvent is for dissolving hyaluronic acid or a hyaluronate, and purified water or an aqueous ethanol solution can be used. The aqueous ethanol solution preferably has an ethanol content of 0.01 to 10% by volume.
[0043] Generally, the pH of hyaluronate is 5.0 to 7.0, and hyaluronic acid solutions are vulnerable to microbial contamination, so antibacterial agents such as ethanol must be added to prevent this. However, when hyaluronic acid with a pH of 2.5 to 3.5 is used, it has excellent microbial contamination prevention effects.
[0044] The filtered hyaluronic acid solution is poured into an automatic coater or mold, and a film is cast to a thickness of 0.02 to 3 mm. The cast film is then dried at 30 to 60°C to produce a hyaluronic acid film with a thickness of 0.01 mm to 1.5 mm.
[0045] If the casting thickness is less than 0.02 mm, it is difficult to form a film, and if the casting thickness exceeds 3 mm, the casting thickness cannot be maintained due to the fluidity of the solution, so that a hyaluronic acid film of 0.01 mm to 1.5 mm can finally be produced.
[0046] The cast film is preferably dried for 6 to 24 hours at 30 to 60° C. The drying can be performed by various drying methods without particular limitation as long as the drying is performed at 30 to 60° C.
[0047] From another aspect, the present invention relates to a cosmetic mask pack, an edible film, a medical device patch, and the like, which contain the hyaluronic acid film. EXAMPLES
[0048] The present invention will be described in more detail below with reference to examples. It will be apparent to those skilled in the art that these examples are merely for the purpose of illustrating the present invention and are not intended to limit the scope of the present invention.
[0049] Example 1: Preparation of hyaluronic acid film by conventional technology A hyaluronic acid film was prepared by the method described in Korean Patent Publication No. 2019-0138907. That is, a glass support was heated to 60°C for 2 hours. Then, 17% by weight of hyaluronic acid based on the total weight of the hyaluronic acid solution was dissolved in distilled water to prepare a hyaluronic acid solution. The heated support (glass) was coated with the dissolved hyaluronic acid solution to a thickness of 500 μm, dried at 60°C for 2 hours, and peeled off to prepare a hyaluronic acid film with a thickness of 80 μm. The molecular weights of the hyaluronic acid used were 500 Da, 2,000 Da, 1×10 5 It was Da.
[0050] As a result, when the molecular weight of hyaluronic acid was 500 Da, no film was formed, when the molecular weight of hyaluronic acid was 2,000 Da, a film was formed but was not smooth, and when the molecular weight of hyaluronic acid was 1×10 5 It was confirmed that when the thickness of the film was 100 nm, a film with a smooth surface was formed.
[0051] Example 2: Preparation of hyaluronic acid film Examples 2-1 to 2-6: Production of ultra-low molecular weight hyaluronic acid films Molecular weight 500~1×10 5 Da ultra-low molecular weight hyaluronate (10-50% by volume) was dissolved in 0.01-10% by volume of ethanol aqueous solution to prepare a hyaluronate solution (100-20,000 cPs). The applicator of the automatic coater was adjusted to cast a film with a thickness of 0.02-3 mm, and then the film was dried at 40°C for 20 minutes to 24 hours using a hot air dryer to prepare a hyaluronate film with a thickness of 0.01-1.5 mm.
[0052] [Table 1]
[0053] As a result, similar to the result of the production by the conventional technique in Example 1, in the case of a molecular weight of 500 Da, no film was formed, and in the cases of molecular weights of 2,000 Da, 8,000 Da, and 10,000 Da, although a film was formed, the film was easily cracked and broken, and the molecular weight of 3×10 4 It was confirmed that when the melting point was 100 Da or more, a film with a smooth surface was formed.
[0054] Examples 2-7 to 2-23: Production of hyaluronic acid films using ultra-low and medium molecular weight As shown in Table 2 below, 1×10 5 ~1×10 6 A medium molecular weight hyaluronate (pH 6.0-7.0) with a molecular weight of 2,000-10,000 Da and an ultra-low molecular weight hyaluronate (pH 6.0-7.0) with a molecular weight of 2,000-10,000 Da were mixed and dissolved in purified water to produce a hyaluronate solution with a viscosity of 2,000-25,000 cPs. The solution was sieved (mesh size: 0.1 mm) and the applicator of the automatic coater was adjusted to cast the hyaluronate solution to a thickness of 0.02-3 mm, and then dried at 40°C for 20 minutes to 24 hours using a hot air dryer to produce a hyaluronate film with a thickness of 0.01-1.5 mm.
[0055] [Table 2]
[0056] From Figure 1, molecular weights of 2,000 to 1×10 4 When Da's ultra-low molecular weight hyaluronate is used alone, it is confirmed that film formation is impossible due to the surface cracking and uneven shape. However, when ultra-low molecular weight hyaluronate and medium molecular weight hyaluronate are mixed in a specific ratio, it is confirmed that mass production of a film with a uniform surface is possible (see Figure 2).
[0057] From Table 2, it was confirmed that when the viscosity of the hyaluronate solution is less than 2,000 cPs, it is difficult to form a film, and when the viscosity of the hyaluronate solution is 25,000 cPs or more, it is difficult to cast a film with a thickness of 0.02 to 3 mm using an automatic applicator due to its high viscosity.
[0058] In addition, when the casting thickness was set to 3.5 mm, it was confirmed that the thickness of the hyaluronate solution was not maintained and it spread, making casting impossible (see 2-21).
[0059] Examples 2-24 to 2-26: Preparation of hyaluronic acid films by pH Hyaluronic acid films were produced in the same manner as in Examples 2-9, 2-11, and 2-13, except that hyaluronic acid having a pH of 2.5 to 3.5 was used instead of hyaluronate having a pH of 6.0 to 7.0, and their stability against microorganisms was evaluated.
[0060] [Table 3]
[0061] The prepared hyaluronic acid and hyaluronate films were each dissolved in sterile saline at a volume of 1%, and 1 mL of each was applied to 3M petrifilm. After incubation at 37°C for 24 hours, the presence or absence of microbial contamination was confirmed. The results are shown in Table 4.
[0062] [Table 4]
[0063] From Table 4, it can be seen that when a hyaluronate salt with a pH of 6.0 to 7.0 is used, there is a risk of microbial contamination occurring during the film manufacturing process, but when hyaluronic acid with a pH of 2.5 to 3.5 is used, no microbial contamination occurs (see Figure 3).
[0064] Examples 2-27 to 2-29: Production of hyaluronic acid films with and without filtration Hyaluronate films were produced in the same manner as in Examples 2-9, 2-11, and 2-13, except that the films were cast without filtering the hyaluronate solution, and the quality of the hyaluronate films was confirmed.
[0065] [Table 5]
[0066] From Table 5 and FIG. 4, it was found that when the hyaluronic acid solution was sieved (mesh size: 0.1 mm) before casting, no air bubbles were generated and a good film without impurities was formed, whereas when the hyaluronic acid solution was not sieved, air bubbles were generated in the film or impurities were contained.
[0067] Example 3: Evaluation of percutaneous absorption rate The percutaneous absorption rate of high molecular weight hyaluronate film is compared with that of the ultralow molecular weight hyaluronate film produced in the embodiment.Except that the high molecular weight hyaluronate film uses the hyaluronate with molecular weight of 1.2MDa in 100% by weight, the hyaluronate film is produced in the same manner as in embodiment 2-9, and the percutaneous absorption rate is measured.
[0068] According to the "Guideline for Skin Absorption Tests in Living Organisms," a Franz diffusion cell (effective area: 0.64 cm) was used. 2 The skin permeation test was carried out under sink conditions using a 5 ml (containment chamber volume) apparatus (Logan Instruments, New Jersey, USA).
[0069] Phosphate buffered saline (PBS) with a pH of 7.4 was used as the receptor phase for the skin permeation test. The epidermal layer of the prepared human skin (1.5 cm x 1.5 cm) was placed on the receptor chamber with the stratum corneum facing up, and the donor chamber was covered and fixed with a clamp. The receptor phase was then filled into a Franz diffusion cell and maintained at 32 ± 1°C. 100 μl of hyaluronic acid film solution was applied to the donor site at a constant temperature to perform the permeation experiment. After 1 hour, 3 hours, 6 hours, 9 hours, 12 hours, and 24 hours had passed since the permeation experiment, 5 ml of the receptor phase was collected and analyzed, and was replenished with fresh phosphate buffered saline.
[0070] [Table 6]
[0071] From Table 6, 1.2 x 10 6 When using Da high molecular weight hyaluronate, the percutaneous absorption rate of the film was 33.12%, but the percutaneous absorption rate of the hyaluronate film made by mixing ultra-low molecular weight and medium molecular weight hyaluronate was 71.50-93.63%, proving to be even better. In particular, it was confirmed that the smaller the molecular weight, the greater the increase in percutaneous absorption rate, and that the thinner the hyaluronate film, the greater the percutaneous absorption rate.
[0072] Although the specific parts of the present invention have been described in detail above, it is obvious to those skilled in the art that such specific techniques are merely preferred embodiments and do not limit the scope of the present invention. Therefore, the substantial scope of the present invention should be defined by the appended claims and their equivalents. [Industrial Applicability]
[0073] The hyaluronic acid film of the present invention is composed primarily of ultra-low molecular weight hyaluronic acid, and has excellent percutaneous absorption rate and mechanical properties, making it applicable to a variety of uses such as cosmetic packs, medical device patches, and health functional foods.
Claims
1. A hyaluronic acid film with a transdermal absorption rate of 72 to 93%.
2. The hyaluronic acid has a molecular weight of 2,000 to 1×10 4 84-98.5% by weight of hyaluronic acid of Da and a molecular weight of 1×10 5 ~1×10 6 2. The hyaluronic acid film according to claim 1, characterized in that it is composed of 1.5 to 16% by weight of hyaluronic acid of Da.
3. The hyaluronic acid film according to claim 1, characterized in that the thickness of the hyaluronic acid film is 0.01 to 1.5 mm.
4. The hyaluronic acid film according to any one of claims 1 to 3, wherein the hyaluronic acid is hyaluronic acid, a hyaluronate salt or a mixture thereof.
5. (a) Molecular weight 2,000 to 1×10 4 Da hyaluronic acid and molecular weight 1×10 5 ~1×10 6 and dissolving the resulting mixture in a solvent to prepare a hyaluronic acid solution; (b) filtering the hyaluronic acid solution; (c) pouring the filtered hyaluronic acid solution into an automatic applicator or mold and casting a film to a thickness of 0.02-3 mm; (d) drying the cast film at 30 to 60°C.
6. Molecular weight 2,000-1×10 4 Da hyaluronic acid and molecular weight 1 x 10 5 ~1×10 6 The method for producing a hyaluronic acid film according to claim 5, characterized in that the weight ratio of Da to hyaluronic acid is 84.0-98.5% by weight:1.5-16% by weight.
7. The method for producing a hyaluronic acid film according to claim 5, wherein the viscosity of the hyaluronic acid solution is 2,000 to 25,000 cPs.
8. The method for producing a hyaluronic acid film according to claim 5, wherein the pH of the hyaluronic acid solution is 2.5 to 3.
5.
9. The method for producing a hyaluronic acid film according to any one of claims 5 to 8, wherein the hyaluronic acid is hyaluronic acid, a hyaluronate salt or a mixture thereof.
10. A cosmetic mask pack comprising the hyaluronic acid film according to claim 1.
11. An edible film comprising the hyaluronic acid film according to claim 1.
12. A patch for a medical device comprising the hyaluronic acid film according to claim 1.
Citation Information
Patent Citations
Manufacturing method of medical and cosmetic material, and medical and cosmetic material
JP2019044086A
Method for producing hyaluronate film and hyaluronate film produced thereby
JP2020510551A
